General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

RecruitingOBSERVATIONAL
Enrollment

630

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

January 31, 2028

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Insulin Icodec

Participants will be treated with commercially available Awiqli according to routine clinical practice at the discretion of the treating physician.

Trial Locations (43)

963-8851

ENROLLING_BY_INVITATION

Seino Internal Medicine Clinic_Internal medicine, Koriyama-shi

862-0976

ENROLLING_BY_INVITATION

Jinnouchi Hospital_Internal Medicine, Kumamoto

448-0852

ENROLLING_BY_INVITATION

Miyachi Clinic, Aichi

468-0009

ENROLLING_BY_INVITATION

Clinic Tosaki, Aichi

485-0044

ENROLLING_BY_INVITATION

Uenishi Internal Medicine Clinic, Aichi

494-0001

NOT_YET_RECRUITING

Ichinomiyanishi Hospital, Aichi

030-0823

ENROLLING_BY_INVITATION

Ohisama Clinic_Aomori, Aomori

038-0011

ENROLLING_BY_INVITATION

Kakizaki Tonyobyo Naika Clinic, Aomori

264-0017

ENROLLING_BY_INVITATION

Chiba Central Medical Center, Chiba

292-0822

ENROLLING_BY_INVITATION

Kimitsu Chuo Hospital_Diabetology and Endocrinology, Chiba

790-0026

ENROLLING_BY_INVITATION

Soyokaze CardioVascular Medicine and Diabetes Care, Ehime

815-0071

ENROLLING_BY_INVITATION

Clinic Masae Minami, Fukuoka

818-0024

ENROLLING_BY_INVITATION

Ito Naika Clinic_Internal Medicine, Fukuoka

670-0837

ENROLLING_BY_INVITATION

Takabe Diabetes Clinic, Hyogogoken

651-0086

ENROLLING_BY_INVITATION

Kagayaki Diabetes and Endocrinology Clinic Sannomiya_Diabetes Internal Medicine, Hyōgo

651-2135

ENROLLING_BY_INVITATION

Matsuda Diabetes Clinic, Hyōgo

656-0021

ENROLLING_BY_INVITATION

Hyogo Prefectural Awaji Medical Center_Diabetes and Endocrinology, Hyōgo

769-1695

ENROLLING_BY_INVITATION

Mitoyo General Hospital_Internal Medicine, Kagawa

222-0036

ENROLLING_BY_INVITATION

Yokohama Rosai Hospital_Diabetes and Endocrinology, Kanagawa

235-0045

NOT_YET_RECRUITING

H.E.C Science Clinic, Kanagawa

236-0033

ENROLLING_BY_INVITATION

Kikuchi Naika Clinic_Kanagawa, Kanagawa

292-0038

ENROLLING_BY_INVITATION

Hotaruno hakuyukai Medical Corporation of Japan, Kisarazu-shi, Chiba

606-8507

ENROLLING_BY_INVITATION

Kyoto University Hospital, Kyoto-shi, Kyoto

516-0035

NOT_YET_RECRUITING

MG Clinic, Mie

181-0013

ENROLLING_BY_INVITATION

Kanno Naika_Internal Medicine, Mitaka-shi, Tokyo

399-4511

ENROLLING_BY_INVITATION

Minamiminowa Clinic_Internal Medicine and Endocrinology and Metabolism, Nagano

942-0052

ENROLLING_BY_INVITATION

Minagawa Clinic Internal Medicine, Niigata

024-0061

ENROLLING_BY_INVITATION

Kitakamiekimae Naika Clinic, Numakunai

545-0053

ENROLLING_BY_INVITATION

Osaka General Hospital of West Japan Railway Company_Diabetes and Metabolism, Osaka

581-0869

ENROLLING_BY_INVITATION

Ogawa Clinic, Osaka

591-8006

ENROLLING_BY_INVITATION

Matsuda Gastroenterology and Diabetes Clinic, Osaka

879-7301

ENROLLING_BY_INVITATION

Okamoto Clinic for Diabetes and Endocrinology, Ōita

849-4193

RECRUITING

Imari Arita Kyoritsu Hospital_Internal Medicine, Saga

697-0062

ENROLLING_BY_INVITATION

Yamane Hospital, Shimane

430-0802

ENROLLING_BY_INVITATION

Kikuchi Medical Clinic, Shizuoka

105-0004

ENROLLING_BY_INVITATION

Aoi Clinic_Diabetes and Internal Medicine, Tokyo

105-8471

NOT_YET_RECRUITING

The Jikei University Hospital Dept of Diabetes, Metabolic, Tokyo

150-0013

ENROLLING_BY_INVITATION

Matsuura Clinic, Tokyo

153-0051

ENROLLING_BY_INVITATION

Mishuku Hospital, Tokyo

153-8934

ENROLLING_BY_INVITATION

Tokyo Kyosai Hospital_Diabetes and Endocrinology, Tokyo

158-8531

ENROLLING_BY_INVITATION

Kanto Central Hospital of the Mutual Aid Association of Public School Teachers_Diabetes and Endocrinology, Tokyo

206-0033

ENROLLING_BY_INVITATION

Tamacenter Clinic Mirai, Tokyo

683-0012

ENROLLING_BY_INVITATION

Honda Clinic_Internal Medicine, Tottori

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT06807190 - General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus | Biotech Hunter | Biotech Hunter